Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cocrystal Pharma names interim CEO

This article was originally published in Scrip

Executive Summary

Dr Gary Wilcox has stepped down as CEO of Cocrystal Pharma – a company focused on developing novel antiviral therapeutics for human diseases – due to medical reasons. As a result, Jeffrey Meckler has been appointed interim CEO of the company. Dr Wilcox will become the vice-chair of Cocrystal's board of directors and will continue as a senior advisor to the company. Mr Meckler will continue as a director of the company, and Dr Raymond F Schinazi will become the chair of the board.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts